HDL-C response variability to niacin ER in US adults

Cholesterol

Volumn 2013, Issue , 2013, Pages

  Christian, Jennifer B ^a   Olson, Eric J ^a   Allen, Jeffery K ^a   Lowe, Kimberly A ^b  

^a GLAXOSMITHKLINE   (United States)

^b EXPONENT INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RELEASE; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; LIPID ANALYSIS; MALE; PREDICTION; PRIORITY JOURNAL; TREATMENT RESPONSE; UNITED STATES;

EID: 84875410522     PISSN: 20901283     EISSN: 20901291     Source Type: Journal    
DOI: 10.1155/2013/681475     Document Type: Article

References (17)

1. Ansell B. J., Watson K. E., Fogelman A. M., Navab M., Fonarow G. C., High-density lipoprotein function: recent advances. Journal of the American College of Cardiology 2005 46 10 1792 1798 2-s2.0-27644587961 10.1016/j.jacc.2005.06.080 (Pubitemid 41579798)
2. Morrison A., Hokanson J. E., The independent relationship between triglycerides and coronary heart disease. Vascular Health and Risk Management 2009 5 89 95 2-s2.0-67449100023
3. Schaefer E. J., Lamon-Fava S., Ordovas J. M., Cohn S. D., Schaefer M. M., Castelli W. P., Wilson P. W. F., Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. Journal of Lipid Research 1994 35 5 871 882 2-s2.0-0028200951 (Pubitemid 24157238)
4. Boden W. E., Probstfield J. L., Anderson T., Chaitman B. R., Desvignes-Nickens P., Koprowicz K., McBride R., Teo K., Weintraub W., Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. The New England Journal of Medicine 2011 365 24 2255 2267 10.1056/NEJMoa1107579
5. Prevalence of abnormal lipid levels among youths-United States, 1999-2006. MMWR. Morbidity and Mortality Weekly Report 2010 59 2 29 33
6. Birjmohun R. S., Kastelein J. J. P., Poldermans D., Stroes E. S. G., Hostalek U., Assmann G., Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients. Current Medical Research and Opinion 2007 23 7 1707 1713 2-s2.0-34547205154 10.1185/030079907X199682 (Pubitemid 47122180)
7. Toth P. P., Zarotsky V., Sullivan J. M., Laitinen D., Niacin and fibrate use among patients with high triglycerides and low high-density lipoprotein cholesterol. Current Medical Research and Opinion 2009 25 6 1355 1363 2-s2.0-67649422332 10.1185/03007990902910450
8. Christian J. B., Bourgeois N. E., Lowe K. A., Prevalence, clinical characteristics and treatment patterns of low high-density lipoprotein cholesterol in the US population: National Health and Nutrition Examination Survey 2005-2008. Journal of Cardiovascular Medicine 2011 12 10 714 722 10.2459/JCM.0b013e328349c4e5
9. Toth P. P., Zarotsky V., Sullivan J. M., Laitinen D., Dyslipidemia treatment of patients with diabetes mellitus in a US managed care plan: a retrospective database analysis. Cardiovascular Diabetology 2009 8 article 26 2-s2.0-67650074103 10.1186/1475-2840-8-26
10. Alemayehu B., Buysman E., Parry D., Becker L., Nathan F., Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population. Journal of Medical Economics 2010 13 2 351 361 2-s2.0-77953348701 10.3111/13696998.2010. 491435
11. Christian J. B., Arondekar B., Buysman E. K., Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia. Journal of Clinical Lipidology 2012 6 5 450 461 10.1016/j.jacl.2012.08.007
12. Williams S. A., Buysman E. K., Hulbert E. M., Hemoglobin A1c outcomes and health care resource use in type 2 diabetes mellitus patients treated with combination oral antidiabetic drugs through step therapy and loose-dose and fixed-dose combinations. Managed Care 2012 21 40 48
13. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 25 3143 3421
14. Jacobson T. A., A "hot" topic in dyslipidemia management-"how to beat a flush": optimizing Niacin tolerability to promote long-term treatment adherence and coronary disease prevention. Mayo Clinic Proceedings 2010 85 4 365 379 2-s2.0-77950670133 10.4065/mcp.2009.0535
15. Kamal-Bahl S., Watson D. J., Ambegaonkar B. M., Patients' experiences of niacin-induced flushing in clinical practice: a structured telephone interview. Clinical Therapeutics 2009 31 1 130 140 2-s2.0-60349085760 10.1016/j.clinthera. 2009.01.011
16. Shear C. L., Franklin F. A., Stinnett S., Hurley D. P., Bradford R. H., Chremos A. N., Nash D. T., Langendorfer A., Expanded Clinical Evaluation of Lovastatin (EXCEL) Study results: effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins. Circulation 1992 85 4 1293 1303 2-s2.0-0026609034
17. Wierzbicki A. S., Mikhailidis D. P., Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies. International Journal of Cardiology 2002 84 1 53 57 2-s2.0-0036289398 10.1016/S0167-5273(02)00118-3 (Pubitemid 34718090)